Results 151 to 160 of about 98,742 (244)

Occurrence and Antimicrobial Resistance Profiles of <i>Escherichia coli</i> along the Sheep Meat Production Chain: A One Health Approach. [PDF]

Int J Vet Sci Med
Sumaila N, Adzitey F, Abu A, Monten SKK, Hermantoi FE, Susilo A, Rahayu PP, Apriliyani MW, Huda N.   +8 more
europepmc   +1 more source

Risk Factors and Management of Gingival Enlargement: A Systematic Review and Meta‐Analysis

Journal of Clinical Periodontology, EarlyView.
ABSTRACT Objective To identify risk factors/indicators of gingival enlargement (GE) and to summarise evidence for its management. Methods A systematic review was undertaken following PRISMA guidelines and divided into PECOTS and PICOTS questions, related to risk factors/indicators and treatment studies, respectively.
Luigi Nibali, Emily Ming‐Chieh Lu, Helvis E. S. Paz, Jing Kang, Nagihan Bostanci, Georgios N. Belibasakis   +5 more
wiley   +1 more source

Explainable Stacked Ensemble Learning for Predicting Antibiotic Residues in the Danube River Within the Territory of the City of Novi Sad, Serbia. [PDF]

Antibiotics (Basel)
Kekić D, Jovićević M, Šovljanski O, Tomić A, Pezo L, Mirković N, Novaković R, Vićić I, Bajčetić N, Tolić Stojadinović L, Grujić S, Mirković M, Karabasil N, Opavski N, Gajić I.   +14 more
europepmc   +1 more source

Copaiba Balsam‐Induced Contact Dermatitis Mimicking Wells' Cellulitis in a Child

Contact Dermatitis, EarlyView.
Nathalia Bellon, Angéline Girault, Morgane Seyler, Annonciade Frassati‐Biaggi, Anne Welfringer, Christine Bodemer   +5 more
wiley   +1 more source

Management of Periodontal Abscesses and Endodontic‐Periodontal Lesions—A Systematic Review

Journal of Clinical Periodontology, EarlyView.
ABSTRACT Aim To evaluate the management of periodontal abscesses and endodontic‐periodontal lesions (EPLs). Methods Seven focused questions addressed outcomes such as pocket depth (PD), bleeding on probing (BOP), tooth loss or ovoid elevation. The literature search covered three electronic databases and manual sources for intervention studies.
Henrik Dommisch, Daniela Hoedke, Marina Dourou, Elena Calciolari, David Herrera, Selena Toma   +5 more
wiley   +1 more source

Antibacterial Efficacy of Local Therapeutic Agents Against Specific Gram-Positive Bacteria Associated with Pericoronitis. [PDF]

Biomedicines
Toranbeki Ö, Caymaz MG, Elver A, Güvenir M.   +3 more
europepmc   +1 more source

Cleanse, Perfuse, Retain (CPR) Protocol for Management of Postoperative Infections With d‐PTFE Membranes: Clinical Reports of Three Cases

Journal of Esthetic and Restorative Dentistry, EarlyView.
ABSTRACT Objective Postoperative infection is a serious complication of bone augmentation procedures, potentially resulting in graft failure, basal bone resorption, and spread of infection to adjacent anatomic spaces. This paper introduces the CPR (Cleanse, Perfuse, and Retain) protocol and illustrates its clinical application in the management of low‐
Istvan A. Urban, Zhaozhao Chen, Hom‐Lay Wang   +2 more
wiley   +1 more source

Comparison of Keverprazan-based versus esomeprazole-based dual therapy for initial treatment of <i>Helicobacter pylori</i> infection: a prospective, multicenter, randomized controlled trial. [PDF]

Ann Med
Ma Z, Gou X, Ma H, Lu H, Liu M, Yuan H, Li Q, Wang J, Yang H, Wang Y, Chen Z, Shu X, Zhao Y, Li C, Li W, Zheng Y, Ji R, Ren Q.   +17 more
europepmc   +1 more source

Modified Osseodensification Bur (Sun Bur) for Transcrestal Sinus Floor Elevation With 2–6 mm Residual Bone Height: A Retrospective Cohort Study

Journal of Esthetic and Restorative Dentistry, EarlyView.
ABSTRACT Objective To evaluate the clinical efficacy of a modified osseodensification (OD) bur for transcrestal sinus floor elevation (tSFE) and to compare clinical outcomes between patients with residual bone height (RBH) of 2–< 4 mm (Group A) and 4–6 mm (Group B).
Mingxu Sun, Xian Ding, Zhaozhao Chen, Chongxia Yue, Hom‐Lay Wang   +4 more
wiley   +1 more source

Bismuth-Amoxicillin-Vonoprazan Triple, Amoxicillin-Vonoprazan Dual, and Clarithromycin-Based Triple Therapies for First-Line Treatment of Helicobacter pylori Infection: A Multicenter, Open-Label, Randomized Trial. [PDF]

Helicobacter
Hsu PI, Sheu MJ, Chen CL, Lei WY, Shih CA, Tsay FW, Kao SS, Shie CB, Wu PJ, Kuo CH, Yang JC, Chen KY, Chuah SK, Lee CL, Lee HC, Tai WC, Tsai TJ, Kao JY, Wu DC, Taiwan Acid‐related Disease & Microbiota (TARD‐M) Consortium.   +19 more
europepmc   +1 more source